Devices › Automated insulin dosing device system, single hormonal control
Device brand name · Artificial pancreas device system single hormonal control
MiniMed 780G OUS System BLE Connect 3.0 mg/dL: medical device reports filed with FDA
14,458 reports name it, 2020–2026. Manufacturer given most often on reports: Medtronic Puerto Rico Operations. Product code OZP.
- 14,458
- device reports naming the brand
- 0.1% of all MAUDE reports · about 2,555 a year
- 340
- reports, 12 months to August 2026
- 576 in the 12 months before
- 98.3%
- classified as malfunction
- 85.6% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
FDA's MAUDE database holds 14,458 reports that name the brand "MiniMed 780G OUS System BLE Connect 3.0 mg/dL" (artificial pancreas device system single hormonal control), received between November 2020 and August 2026; the manufacturer given most often on reports is Medtronic Puerto Rico Operations. Spellings of one product vary from report to report.
340 reports arrived in the 12 months to August 2026, down 41% from 576 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (98.3%) and injury (1.7%); across all automated insulin dosing device system, single hormonal control reports (product code OZP) death is recorded in 0.1% and malfunction in 85.6%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are power problem (28.1%), material integrity problem (14%) and break (11.9%). The patient problems coded most often are hyperglycemia, hypoglycemia and elevated ketones/ diabetic ketoacidosis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 893,215 reports carrying product code OZP. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Power problem | 4,064 | 28.1% | 15.8% |
| Material integrity problema problem with the device material | 2,017 | 14% | 7.2% |
| Breakthe device broke | 1,715 | 11.9% | 16.1% |
| Obstruction of flow | 1,166 | 8.1% | 11.7% |
| Computer software problema software problem | 947 | 6.6% | 2% |
| No display/image | 895 | 6.2% | 7.1% |
| Mechanical problema mechanical problem | 788 | 5.5% | 5.3% |
| Moisture or humidity problem | 688 | 4.8% | 3.9% |
| Insufficient flow or under infusion | 636 | 4.4% | 2.5% |
| Loss of data | 623 | 4.3% | 0.8% |
| Circuit failure | 552 | 3.8% | 2.2% |
| Device difficult to program or calibrate | 464 | 3.2% | 2.7% |
| Electrical /electronic property probleman electrical or electronic problem | 424 | 2.9% | 1% |
| Battery problema problem with the battery | 381 | 2.6% | 5.2% |
| Insufficient device problem information | 315 | 2.2% | 1.4% |
| Visual prompts will not clear | 245 | 1.7% | 0.6% |
| Device alarm system | 240 | 1.7% | 2% |
| Wireless communication problema wireless connection problem | 231 | 1.6% | 5.2% |
| Communication or transmission problemthe device could not communicate or transmit | 218 | 1.5% | 2.3% |
| Display or visual feedback problem | 196 | 1.4% | 2.2% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Hyperglycemiahigh blood sugar | 1,080 | 7.5% |
| Hypoglycemialow blood sugar | 267 | 1.8% |
| Elevated ketones/ diabetic ketoacidosis | 44 | 0.3% |
| Discomfortdiscomfort | 38 | 0.3% |
| Nauseafeeling sick | 29 | 0.2% |
| Headachehead pain | 15 | 0.1% |
| Vomitingbeing sick | 14 | 0.1% |
| Abdominal painstomach or belly pain | 11 | 0.1% |
| Fatiguetiredness | 10 | 0.1% |
| Loss of consciousnesspassing out | 8 | 0.1% |
| Appropriate clinical signs, symptoms and conditions term/code not available | 6 | 0% |
| Confusion/ disorientation | 5 | 0% |
| Dyspneashortness of breath | 5 | 0% |
| Dizzinesslight-headedness or unsteadiness | 4 | 0% |
| Painpain, site not specified | 4 | 0% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | MiniMed 780G OUS System BLE Connect 3.0 mg/dL | Product code OZP | All MAUDE reports |
|---|---|---|---|
| Reports | 14,458 | 893,215 | 26,136,888 |
| Share of that pool | — | 1.6% | 0.1% |
| Classified as death, per 1,000 reports | 0 | 1 | 9 |
| Classified as injury | 1.7% | 14.3% | 36.2% |
| Classified as malfunction | 98.3% | 85.6% | 62.3% |
| Filed by the manufacturer | 100% | 99.9% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code OZP
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Pump MMT-1780KPK 670G Pathway Black MG | 224,556 | 835 | 0.2% |
| MiniMed 780G US System BLE Connect 3.0 mg/dL | 112,817 | 57,140 | 0.1% |
| MiniMed 770G US System BLE Connect 3.0 mg/dL | 84,685 | 4,838 | 0.2% |
| Pump 1886 780G OUS BLE Pump mg/dL | 84,259 | 36,883 | 0% |
| 670G Insulin Pump MMT-1780KL | 78,230 | 1,121 | 0.2% |
| MiniMed 780G OUS System BLE Connect 3.0 mmol/L | 66,718 | 19,194 | 0% |
| PUMP MMT-1884L MM780G BLE 3.0 mg/ml | 34,846 | 9,703 | 0.1% |
| Pump Mmt-1880l Mm770g Ble Mg | 24,045 | 3,148 | 0.2% |
| Pump Mmt-1782k 670g V4 11 Mm | 23,587 | 137 | 0.1% |
| Pump Mmt-1781k 670g V4 11 Mg | 17,081 | 617 | 0% |
| Xmtr Mmt-7811xww Gst3c Ous | 16,414 | 111 | 0% |
| Xmtr MMT-7811NA GST3C Lockout | 17,012 | 65 | 0% |
| Guardian Link 3 US | 11,310 | 229 | 0% |
| Pump Mmt-1780k 670g 3ml Black | 9,345 | 9 | 0.2% |
| Unknown NGP | 9,025 | 3,982 | 0.8% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about MiniMed 780G OUS System BLE Connect 3.0 mg/dL reports
How many FDA reports name MiniMed 780G OUS System BLE Connect 3.0 mg/dL?
14,458 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 340 in the latest 12 months.
What kinds of events are reported?
malfunction (98.3%) and injury (1.7%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
power problem (28.1%), material integrity problem (14%), break (11.9%), obstruction of flow (8.1%) and computer software problem (6.6%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that MiniMed 780G OUS System BLE Connect 3.0 mg/dL was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.